Background and Purpose-Stroke survivors have identified home-time as a meaningful outcome. We evaluated home-time as a patient-centered outcome in Medicare beneficiaries with ischemic stroke in comparison with modified Rankin Scale (mRS) score at 90 days and at 1 year post event. Methods-Patients enrolled in Get With The Guidelines-Stroke (GWTG-Stroke) and Adherence Evaluation After Ischemic Stroke-Longitudinal (AVAIL) registries were linked to Medicare claims to ascertain home-time, defined as time spent alive and out of a hospital, inpatient rehabilitation, or skilled nursing facilities, at 90 days and at 1 year after admission. The correlation of home-time with mRS at 90 days and at 1 year was evaluated by Pearson correlation coefficients, and the ability of home-time to discriminate mRS (0-2) was assessed by c-index. 
R eliable assessment of functional status after acute ischemic stroke is vital for clinical trials, quality of care and clinical effectiveness research, and quality improvement programs. 1 Although there are several measures available to assess functional outcomes after acute ischemic stroke including the modified Rankin Scale (mRS) and the Barthel Index, these scales have potential limitations including significant interobserver variability. [1] [2] [3] [4] [5] Moreover, these indexes are not uniformly collected in routine clinical practice, and thus frequently not available in clinical registries, electronic health records, or administrative data sets. 1 In addition, even when part of a prospective functional outcome assessment, incomplete follow-up may contribute to missing data. Home-time has been previously defined as the number of days after stroke onset that a patient spends in their own home or in that of a relative as opposed to within institutional care of any sort. 5 This has been proposed as a graded and objective functional outcome measure for international acute ischemic stroke trials and has been shown to correlate with mRS in clinical trial populations and demonstrate gains in response to effective stroke therapies, such as intravenous tissue-type plasmiogen activator and mechanical thrombectomy treatment. [5] [6] [7] More recently, stroke survivors have identified home-time as a meaningful and highly prioritized outcome. [8] [9] [10] Home-time may thus represent an outcome measure that is more easily understood by patients with stroke, their families, and clinicians.
Although home-time has been studied in clinical trials, there are few data assessing home-time outside of this specific setting. In addition, although home-time could be potentially be calculated using administrative claims data, it has not yet been evaluated when collected this way. We hypothesized that home-time can be measured using administrative claims data allowing for an objective, reliable, and reproducible outcome measure that can be obtained prospectively or retrospectively. In this study, we aimed to evaluate home-time as a patientcentered outcome in Medicare beneficiaries with ischemic stroke and compared it with mRS scores at 90 days and 1 year post event. In addition, we determined baseline patient characteristics that were independently associated with home-time.
Methods
This study used data from the American Heart Association's Get With The Guidelines-Stroke (GWTG-Stroke) program, the Adherence Evaluation After Ischemic Stroke-Longitudinal (AVAIL) study, and Medicare claims. The GWTG-Stroke program is a national, ongoing, voluntary, hospital registry, and performance improvement initiative for acute stroke. 11 Standardized data collection in GWTG-Stroke includes patient demographics, medical history, diagnostic testing, brain imaging, in-hospital treatment, discharge medications, and inpatient outcomes. The eligibility of each admission is confirmed through chart review. The validity and reliability of data collection in the GWTG-Stroke database has been reported previously. 12 The AVAIL study was a prospective national cohort study designed to examine medication adherence, clinical, and functional outcomes at 3 and 12 months after acute ischemic stroke and was implemented in conjunction with GWTG-Stroke. 13 From 2006 to 2008, study personnel at 101 GWTG-Stroke participating hospitals screened patients for AVAIL eligibility during the hospitalization and then obtained informed consent. To be eligible, adults aged ≥18 years had to be hospitalized with a primary diagnosis of ischemic stroke or transient ischemic attack, able to provide informed consent or have a legally authorized representative sign, and have data documented in GWTGStroke. 13 Patients or their designated proxy were subsequently contacted by telephone 3 and 12 months after discharge from their acute hospitalization. Trained research personnel used standard scripts to conduct the telephone interview that included standardized assessments. Medicare is a national health insurance program in the United States, administered by the federal government.
14 Medicare provides health insurance for beneficiaries aged ≥65 years who have worked and paid into the system. For adults aged ≥65 years, >90% are covered by Medicare, and, on average, Medicare covers about half of the healthcare charges for those enrolled. Medicare beneficiaries cover the remaining approved charges either with supplemental insurance or with another form of out-of-pocket coverage.
To obtain longitudinal outcomes from Medicare claims, a previously validated deterministic matching technique was used to link inhospital data from GWTG-Stroke to Medicare claims data. 14 We used a set of indirect patient identifiers to link data from patients with acute ischemic stroke admitted to GWTG-Stroke Hospitals to Medicare Inpatient (Part A) claims. This linkage method has been successfully completed and validated using Medicare inpatient claims. 15 Previous work has demonstrated that patients in the linked GWTG-Stroke/ Medicare database are representative of the national Medicare ischemic stroke population. 15 We excluded patients who were not linked to Medicare data or nonindex cases, patients who were transferred out and those discharged to hospice. The study population was further confined to those patients with acute ischemic stroke enrolled in AVAIL (n=768). As AVAIL did not include patients who died in hospital, we estimated that number using data from the overall GWTG-Stroke population. We matched each AVAIL patient to 50 GWTG-Stroke patients based on age. In the matched GWTG-Stroke patients, we obtained the ratio of patients who died in-hospital versus who were discharged alive. We applied that ratio (0.061) to 768 patients to estimate that 47 patients would have died in-hospital during the time period AVAIL was enrolling patients. We then included 47 patients from GWTG-Stroke that had in-hospital deaths together with the AVAIL cohort for analyses that started with the day of admission and included in-hospital deaths. The final study population consisted of 815 patients from 88 hospitals.
Hospitals participating in GWTG-Stroke and AVAIL obtained institutional review board approval. In addition, the data analysis center obtained institution review board approval for linking to Medicare claims files and for this study. Quintiles served as the data collection coordinating center for GWTG-Stroke. The Duke Clinical Research Institute served as the data collection coordinating center for AVAIL and serves as the data analysis center for both GWTG-Stroke and AVAIL.
Outcomes
Home-time has been previously identified based on patient survey and focus groups as an outcome that is among the most relevant and meaningful to stroke survivors. [7] [8] [9] For this study, home-time was defined as the total number of days alive and out of acute care hospitals, inpatient rehabilitation, or skilled nursing facilities from the first day forward of index hospital admission for acute ischemic stroke. Inpatient days in these settings were identified in Medicare inpatient and skilled nursing facility claims. 9 Where applicable, the date of death was determined through the Medicare denominator files. The date(s) of readmission(s) were ascertained from the hospital claims data submitted to Centers for Medicare and Medicaid Services, and dates of inpatient rehabilitation and skill nursing home visits were obtained by claims data as well. The primary analysis was conducted on the expanded cohort, and home-time was calculated starting from the start date of acute ischemic stroke hospitalization. The 47 patients who died in hospital were assigned a value of zero days home and mRS score of 6. Sensitivity analyses were performed analyzing home-time determined from the date of index hospital discharge, excluding patients with in-hospital death. To obtain an accurate measure of home-time, coverage by fee-for-service Medicare must be active during the entire follow-up period, except for deaths. During the 90-day follow-up, there were 9 patients who were excluded for this reason, and during the 1-year follow-up, 31 patients excluded.
The mRS, a global measure of functional status, was collected in AVAIL at 90 days and 1 year. 12 The mRS provides 7 distinct stages of functioning (from 0=no assistance needed to 5=required constant care and 6=dead). Patients or their proxies were asked about functional status using a structured interview for the mRS levels. The mRS was analyzed as an ordinal variable (scores, 0-6). In addition, the mRS was also analyzed as categorical variables for those who are functionally dependent or dead (mRS scores of 3-6) versus not (mRS scores of 0-2) and those living with disability or dead (mRS scores of 2-6) versus not (mRS scores of 0-1). In sensitivity analyses, we examined mRS as an ordinal variable only among survivors (mRS scores of 0-5) and as a categorical variable indicating moderate to severe functional dependence among those who survived 90 days and 1 year after hospital discharge (mRS scores of 3-5) versus (mRS scores of 0-2) and those who survived and were considered to be living with disability (mRS scores of 2-5 = unable to carry out all previous activities, activity, or worse) versus mRS scores of 0 to 1. The mRS was missing in 38 (4.7%) patients at 90 days and 32 (4.1%) patients at 1 year.
Statistical Analyses
Patient and hospital characteristics for the population were described with proportions used to describe categorical variables, means with SDs for normally distributed continuous variables and median with 25th and 75th percentiles for continuous variables with skewed distribution. The distributions of unadjusted home-time and mRS for the study population were presented. The correlation of home-time with mRS at 90 days at and 1 year from admission was evaluated graphically and by Pearson correlation coefficients. In addition, the discrimination of mRS scores of 0 to 2 and mRS scores of 0 to 1 by home-time was assessed by calculating c-indexes at 90 days and at 1 year. A series of sensitivity analyses was performed including (1) To further assess home-time, patient factors associated with 90 day and 1-year home-time were evaluated. Generalized estimating equations were used to model home-time as a proportion of days possible, either 90 days or 365 days. A logit link was used to reflect the fact that home-time is bounded on 2 sides by 0 and 365. Robust, empirical variance estimates were used to account for the fact that the data are not necessarily independent binomial, and the potential for clustering of patients within hospitals. Patient characteristics, assessed at time of hospitalization, were evaluated as candidate variables for model were age, sex, race, and comorbidities, including stroke, ischemic heart disease, diabetes mellitus, peripheral vascular disease, heart failure, atrial fibrillation, prosthetic heart valve, carotid stenosis, hypertension, dyslipidemia, smoking, anemia, chronic obstructive pulmonary disease, dementia, depression, weight loss/malnutrition, renal disease, rheumatic disease, pneumonia, osteoarthritis, osteoporosis, rheumatoid arthritis, substance abuse, surgery, help feeding (gastrostomy, feeding tubes, and others), pulmonary embolism, acute renal failure, urinary tract infection, venous thrombosis, and any malignancy. Odds ratios for the factors selected in the final model are presented with odds >1.0 indicating a factor that is associated with increasing odds of being alive and out of hospital on any given day within 90 days or 1 year. Because National Institutes of Health Stroke Scale (NIHSS) was not available in all patients and difficult to impute, additional models were run confined to patients with NIHSS documented and adjusting for NIHSS together with final model variables (n=552). All P values are 2 sided. All statistical analyses were performed using SAS version 9.3 (SAS Institute, Cary, NC).
Results
This study included 815 patients with acute ischemic stroke from 88 participating hospitals. The characteristics of the patients are shown in Table 1 The correlation of 90 day mRS and home-time within 90 days was assessed graphically as shown in Figure 1 . The Pearson correlation coefficient between 90-day mRS and home-time within 90 days was −0.731 (P<0.0001). Although there was a graded correlation between home-time and mRS at 90 days, for mRS scores of 0, 1, and 2 patients, the differences in home-time days were modest. The c-index of 90-day home-time discriminating 90-day mRS scores of 0 to 2 was 0.837. The c-index of 90-day home-time from admission discriminating 90-day mRS scores of 0 to 1 was 0.794. The graphical comparison of these outcome measures at 1 year is shown in Figure 2 . The Pearson correlation coefficient between 1-year mRS and home-time within 1 year was −0.713 (P<0.0001). For mRS scores of 0, 1, 2, and 3 patients at 1 year, the differences in home-time days were modest. The level of discrimination was high with the c-index of 1-year home-time predicting 1-year mRS scores of 0 to 2 being 0.828. In sensitivity analyses, similar findings were found when home-time was assessed from the time of hospital discharge. Table 2 shows patient characteristic variables that were associated with home-time at 90 days and at 1 year, without adjustment for stroke severity by NIHSS. Table 3 shows those variables associated with home-time at 90 day and a 1 year, with adjustment for stroke severity, among the subgroup of patients were NIHSS was documented. Advancing age and certain comorbid conditions were associated with lower odds of home-time (lesser days at home) at 90 days and at 1 year. Increasing stroke severity was also significantly associated with lower odds of better home-times.
Discussion
In this study of Medicare Beneficiaries hospitalized with acute ischemic stroke, home-time within 90 days was found to be strongly correlated with degree of global disability as determined by the mRS. In addition, there was excellent discrimination of 90-day functional independence (mRS scores of 0-2) by home-time (c-statistic, 0.837). Home-time assessment at 1 year also showed a strong correlation with mRS at 1 year and excellent discrimination of mRS scores of 0 to 2 at 1 year (c-statistic, 0.828). Similar findings were obtained in a variety of sensitivity analyses. In addition, patient variables previously associated with adverse functional outcomes in patients with acute ischemic stroke, including older age and higher presenting stroke severity, were found to be independently associated with worse home-time (fewer days at home). These findings suggest that home-time may be able to serve as a graded, patient-centered outcome measure for ischemic stroke care available from administrative data.
Home-time has been previously evaluated in 1717 patients enrolled in the Glycine Antagonist (gavestinel) in Neuroprotection (GAIN) International Trial. 5 Home-time was found to be associated with changes across mRS and between mRS category differences were associated with different home-times except for mRS scores of 4 to 5. 5 However, correlation measures were neither provided nor levels of agreement assessed. In an analysis of the Stroke Acute Ischemic NXY Treatment (SAINT) I trial, tissue-type plasmiogen activator treatment was associated with a 5.5-day gain in home-time, and home-time was correlated with mRS (R 2 =57.5%; P<0.0001). 6 Stroke severity by NIHSS was also inversely associated with home-time. 6 The findings of the present study extend these findings to a cohort of Medicare Beneficiaries encountered in clinical practice and measuring home-time with administrative data. Home-time was closely correlated with mRS. Clinical variables, including stroke severity by NIHSS, associated with worse functional outcomes in previous studies, Odds ratio indicates the ratio of odds that the patient is home on any given day between presence vs absence of the factor. CI indicates confidence interval; and OR, odds ratio. Odds ratio indicates the ratio of odds that the patient is home on any given day between presence vs absence of the factor. CI indicates confidence interval; NIHSS, National Institutes of Health Stroke Scale; and OR, odds ratio. by guest on May 17, 2017 http://stroke.ahajournals.org/ Downloaded from were independently associated with worse home-time. In addition, this study finds that home-time may also be used to assess time frames beyond 90 days, with home-time at 1 year showing correlation with mRS at 1 year. Additional studies evaluating home-time in time frames beyond 1 year may be of interest.
Home-time has some potential advantages over other indexes such as mRS in its application and interpretation. 5, 6 Even with the use of standardized instruments and formal training, mRS can be limited by interobserver variability. 1, 4 Home-time, can be easily, objectively, and reproducibly measured from clinical or claims data and is not dependent on the level of training and interpretation of those performing the assessment. 5 Home-time obtained from claims data may be more readily available for analysis in circumstances where outcome measures requiring direct follow-up was not feasible or incomplete. In addition, as a continuous measure with an expanded range, home-time as an outcome measure may lend itself to statistical analyses with greater discrimination than potentially more limited categorical or ordinal outcome measures. 6 An additional strength of home-time is that it may be more easily understood by patient and family members than other functional scales and potentially more useful in engaging patients and family members in shared decision making. 5, 8, 9 Home-time may also be an important measure from the perspective of health system administrators and insurers as increased time in the hospital, inpatient rehabilitation, and skilled nursing care facilities entails substantial additional expenditures.
Home-time has been identified as a patient-centered measure of longitudinal outcomes that was prioritized by stroke survivors and stakeholders. [8] [9] [10] Home-time indicates the absence of institutional care, which is a highly valued health state prioritized by stroke survivors, and potentially better reflects patients' preference of living independently in the community. 8 In addition, home-time may more accurately reflect the overall health status of the patient after ischemic stroke, which is also meaningful from patients' perspectives. 10 Even if home-times were not closely correlated with mRS, it still could be considered a meaningful stroke outcome measure in its own right. 10 Nevertheless, it is important to acknowledge that being at home does not equate to the absence of disability. In addition, some components of home-time, such as longer lengths of stay in an inpatient rehabilitation facility, are clinically appropriate and may increase the duration and quality of future home living by allowing time for poststroke rehabilitation and management of poststroke complications. Thus, shorter home-time does not necessarily equate to better care quality or functional outcomes in all circumstances. The use of home-time should be to complement, not replace, mRS or other measures of disability, where the access and resources are available to obtain gold standard measures of disability. Finally, home-time may be influenced by other factors external to the patient including their network of relatives and social supports, access to inpatient rehabilitation and skilled nursing facilities, availability of community resources such as home services, as well as the means to afford poststroke services. These factors may influence home-time in the first 90 days and beyond.
Our study should be interpreted in the context of the following limitations. This was an observational analysis of clinical, registry, and administrative data from hospitals voluntarily participating in GWTG-Stroke and AVAIL and may not apply to different care settings. Our study is restricted to fee-for-service Medicare Beneficiaries in the United States enrolled in AVAIL and, as a result, may not be entirely representative of or generalizable to other patient populations with ischemic stroke or different healthcare systems. Our analysis of home-time was in comparison with mRS, and we did not assess other stroke functional outcome measures. Because of the use of claims data, we could not distinguish whether home-time meant a patient was living in their own home, living at a relative or friend's house, at home with home care services, at home with other community support, in assisted living or long-term care facilities, homeless, or exceeding the Medicare benefit for postacute care. During follow-up, relatively few patients transitioned from fee-for-service Medicare to Medicare Advantage plans, Medicaid, or some other coverage; however, these patients were excluded from the hometime calculation. Stroke severity was not available in all patients. Finally, residual measured or unmeasured confounding may have affected the multivariable analyses.
Conclusions
In a population of older patients with acute ischemic stroke, home-time was closely correlated with and showed an excellent ability to discriminate mRS at 90 days and 1 year. This outcome measure can be readily obtained from claims data and can be reliably assessed from the time of hospital admission or hospital discharge. Home-time may be able to serve as a novel, patient-centered outcome measure for an episode of stroke care. 
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